# Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

> **NCT00184652** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 140 (actual)

## Conditions studied

- Chronic Kidney Disease
- End-Stage Renal Disease

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00184652
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184652, "Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00184652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*